Drug Shortage Report for SANDOZ TRANDOLAPRIL
Report ID | 224183 |
Drug Identification Number | 02325756 |
Brand name | SANDOZ TRANDOLAPRIL |
Common or Proper name | TRANDOLAPRIL |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | TRANDOLAPRIL |
Strength(s) | 2MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100HGC BO |
ATC code | C09AA |
ATC description | ACE INHIBITORS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-04-02 |
Estimated end date | 2024-05-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2024-04-03 | English | Compare |
v2 | 2024-04-02 | French | Compare |
v1 | 2024-04-02 | English | Compare |
Showing 1 to 3 of 3